|
1
|
Hsu CW, Chen YT, Hsieh YJ, Chang KP, Hsueh
PC, Chen TW, Yu JS, Chang YS, Li L and Wu CC: Integrated analyses
utilizing metabolomics and transcriptomics reveal perturbation of
the polyamine pathway in oral cavity squamous cell carcinoma. Anal
Chim Acta. 1050:113–122. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chamoli A, Gosavi AS, Shirwadkar UP,
Wangdale KV, Behera SK, Kurrey NK, Kalia K and Mandoli A: Overview
of oral cavity squamous cell carcinoma: Risk factors, mechanisms,
and diagnostics. Oral Oncol. 121:1054512021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan Y, Wang Z, Xu M, Li B, Huang Z, Qin S,
Nice EC, Tang J and Huang C: Oral squamous cell carcinomas: State
of the field and emerging directions. Int J Oral Sci. 15:442023.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patil VM, Noronha V, Joshi A, Abhyankar A,
Menon N, Dhumal S and Prabhash K: Beyond conventional chemotherapy,
targeted therapy and immunotherapy in squamous cell cancer of the
oral cavity. Oral Oncol. 105:1046732020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parmar A, Macluskey M, Mc Goldrick N,
Conway DI, Glenny AM, Clarkson JE, Worthington HV and Chan KK:
Interventions for the treatment of oral cavity and oropharyngeal
cancer: Chemotherapy. Cochrane Database Syst Rev.
12:CD0063862021.PubMed/NCBI
|
|
6
|
Zhou Y, Wang L, Liu M, Jiang H and Wu Y:
Oral squamous cell carcinoma: Insights into cellular heterogeneity,
drug resistance, and evolutionary trajectories. Cell Biol Toxicol.
41:1012025. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi BH, Hyun S and Koo SH: The role of
BCAA metabolism in metabolic health and disease. Exp Mol Med.
56:1552–1559. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qian L, Li N, Lu XC, Xu M, Liu Y, Li K,
Zhang Y, Hu K, Qi YT, Yao J, et al: Enhanced BCAT1 activity and
BCAA metabolism promotes RhoC activity in cancer progression. Nat
Metab. 5:1159–1173. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McBrayer SK, Mayers JR, DiNatale GJ, Shi
DD, Khanal J, Chakraborty AA, Sarosiek KA, Briggs KJ, Robbins AK,
Sewastianik T, et al: Transaminase inhibition by 2-hydroxyglutarate
impairs glutamate biosynthesis and redox homeostasis in glioma.
Cell. 175:101–116.e25. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu E, Ji B, Jin K and Chen Y:
Branched-chain amino acids catabolism and cancer progression: Focus
on therapeutic interventions. Front Oncol. 13:12206382023.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ananieva EA and Wilkinson AC:
Branched-chain amino acid metabolism in cancer. Curr Opin Clin Nutr
Metab Care. 21:64–70. 2018.PubMed/NCBI
|
|
12
|
Yuan Z, Li M and Tang Z: BCAT1 promotes
cell proliferation, migration, and invasion via the PI3K-Akt
signaling pathway in oral squamous cell carcinoma. Oral Dis.
31:364–375. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deng X, Qing Y, Horne D, Huang H and Chen
J: The roles and implications of RNA m6A modification in
cancer. Nat Rev Clin Oncol. 20:507–526. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hong J, Xu K and Lee JH: Biological roles
of the RNA m6A modification and its implications in
cancer. Exp Mol Med. 54:1822–1832. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang X, Liu B, Nie Z, Duan L, Xiong Q,
Jin Z, Yang C and Chen Y: The role of m6A modification in the
biological functions and diseases. Signal Transduct Target Ther.
6:742021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao W, Cui Y, Liu L, Ma X, Qi X, Wang Y,
Liu Z, Ma S, Liu J and Wu J: METTL3 facilitates oral squamous cell
carcinoma tumorigenesis by enhancing c-Myc stability via
YTHDF1-mediated m6A modification. Mol Ther Nucleic
Acids. 20:1–12. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xu L, Li Q, Wang Y, Wang L, Guo Y, Yang R,
Zhao N, Ge N, Wang Y and Guo C: Yang: m6A
methyltransferase METTL3 promotes oral squamous cell carcinoma
progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA
stability. Am J Cancer Res. 11:5282–5298. 2021.PubMed/NCBI
|
|
18
|
De Kesel J, Fijalkowski I, Pieters T,
Borin C, Christensen KT, Wittouck M, Van Laere J, Guerrero L,
Reunes L, Caruso M, et al: HNRNPC and m6A RNA methylation control
oncogenic transcription and metabolism in T-cell leukemia. Blood.
146:275–290. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bi Z, Liu Y, Zhao Y, Yao Y, Wu R, Liu Q,
Wang Y and Wang X: A dynamic reversible RNA
N6-methyladenosine modification: Current status and
perspectives. J Cell Physiol. 234:7948–7956. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Navickas A, Asgharian H, Winkler J, Fish
L, Garcia K, Markett D, Dodel M, Culbertson B, Miglani S, Joshi T,
et al: An mRNA processing pathway suppresses metastasis by
governing translational control from the nucleus. Nat Cell Biol.
25:892–903. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu Y, Zhao W, Liu Y, Tan X, Li X, Zou Q,
Xiao Z, Xu H, Wang Y and Yang X: Function of HNRNPC in breast
cancer cells by controlling the dsRNA-induced interferon response.
EMBO J. 37:e990172018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Su Z, Liu X, Xu Y, Hu W, Zhao C, Zhao H,
Feng X, Zhang S, Yang J, Shi X and Peng J: Novel reciprocal fusion
genes involving HNRNPC and RARG in acute promyelocytic leukemia
lacking RARA rearrangement. Haematologica. 105:e376–e378. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen JJ, Lu TZ, Wang T, Yan WH, Zhong FY,
Qu XH, Gong XC, Li JG, Tou FF, Jiang LP and Han XJ: The m6A reader
HNRNPC promotes glioma progression by enhancing the stability of
IRAK1 mRNA through the MAPK pathway. Cell Death Dis. 15:3902024.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qin Z, Bai J, He H and Li B: Expression
and significance of m6A-RNA-methylation in oral cancer and
precancerous lesion. Front Oncol. 13:10130542023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Amin MB, Greene FL, Edge SB, Compton CC,
Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR and
Winchester DP: The eighth edition AJCC cancer staging manual:
Continuing to build a bridge from a population-based to a more
‘personalized’ approach to cancer staging. CA Cancer J Clin.
67:93–99. 2017.PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shen L, Qu X, Li H, Xu C, Wei M, Wang Q,
Ru Y, Liu B, Xu Y, Li K, et al: NDRG2 facilitates colorectal cancer
differentiation through the regulation of Skp2-p21/p27 axis.
Oncogene. 37:1759–1774. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Li D, Sun L, Qin H, Fan A, Meng L,
Graves-Deal R, Glass SE, Franklin JL, Liu Q, et al: Interaction of
lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent
stabilization of TCF7L2 mRNA and colorectal cancer progression. Mol
Cancer. 21:742022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tang D, Cao C, Huang S, He Q and Wang A:
YTHDF2 drives oral squamous cell carcinoma progression via
m6A-dependent degradation of MTUS1/ATIP1 mRNA and
mitochondrial dysregulation. Cell Signal. 136:1121452025.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang D, Mai L, Zhang L, Huang G, Lin Z,
Wang S, Rao G, Xie S and Pan C: The m6A reader IGF2BP2
promotes oral squamous cell carcinoma progression by maintaining
UCA1 stability. Recent Pat Anticancer Drug Discov. 20:697–709.
2025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nie C, He T, Zhang W, Zhang G and Ma X:
Branched Chain amino acids: Beyond nutrition metabolism. Int J Mol
Sci. 19:9542018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Duan Y, Li F, Li Y, Tang Y, Kong X, Feng
Z, Anthony TG, Watford M, Hou Y, Wu G and Yin Y: The role of
leucine and its metabolites in protein and energy metabolism. Amino
Acids. 48:41–51. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Su Y, Hu Y, Qu B, Lei R and Guo G: METTL3
promotes OSCC progression by down-regulating WEE1 in a
m6A-YTHDF2-dependent manner. Mol Biotechnol. 67:1867–1879. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu YY, Xia M, Chen ZB, Liao YD, Zhang CY,
Yuan L, Pan YW, Huang H, Lu HW and Yao SZ: HNRNPC mediates
lymphatic metastasis of cervical cancer through m6A-dependent
alternative splicing of FOXM1. Cell Death Dis. 15:7322024.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang N, Liu L, Liu X, Chen Y, Lu J and
Wang Z: hnRNPC promotes malignancy in pancreatic cancer through
stabilization of IQGAP3. Biomed Res Int. 2022:63196852022.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Y, Zhang J, Ren S, Sun D, Huang HY,
Wang H, Jin Y, Li F, Zheng C, Yang L, et al: Branched-chain amino
acid metabolic reprogramming orchestrates drug resistance to EGFR
tyrosine kinase inhibitors. Cell Rep. 28:512–525.e6. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wen H, Tang J, Cui Y, Hou M and Zhou J:
m6A modification-mediated BATF2 suppresses metastasis and
angiogenesis of tongue squamous cell carcinoma through inhibiting
VEGFA. Cell Cycle. 22:100–116. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Liu Y, Sun D, Sun R, Wang X, Li M,
Song N, Ying J, Guo T and Jiang Y: Long noncoding RNA lnc-H2AFV-1
promotes cell growth by regulating aberrant m6A RNA modification in
head and neck squamous cell carcinoma. Cancer Sci. 113:2071–2084.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang Y, Wang Y, Peng J, Zhao K, Li L,
Zhang Y, Zhai Z, Yuan S, Li S, Ye F and Wang L: Expression and
prognostic significance of the m6A RNA methylation regulator HNRNPC
in HNSCC. Front Oncol. 15:15168672025. View Article : Google Scholar : PubMed/NCBI
|